Supernatants from peripheral blood mononuclear cells obtained from certain patients with the acquired immune deficiency syndrome (AIDS) or its prodrome were capable of depressing spontaneous and pokeweed mitogen-driven B lymphocyte differentiation into plasmacytes, and the proliferative responses of T cells to specific antigen. These soluble suppressor factors (SSF) were present in uniquely high concentrations, with significant differences from healthy controls and from patients with various other conditions previously associated with factor-mediated immunosuppression. T cell-independent functions were not modified by SSF. Suppression was not genetically constrained, and did not appear to be mediated by cytotoxicity, prostaglandin, or alpha or gamma interferons. SSF was a product of the interaction of T lymphocytes with adherent cells. T cells or T cell factors from AIDS patients, but not from normal controls, could collaborate with control adherent cells in the formation of SSF. Restoration of DNA synthesis-independent differentiation of B lymphocytes into plasmacytes in SSF-treated cultures was realized by addition of reducing agents, such as 2-mercaptoethanol, on culture initiation. These data suggest inhibitory mechanisms possibly related to that of concanavalin A-induced soluble immune response suppression, and perhaps offer clues to clinically applicable substances which are potentially capable of mitigating such responses.
J Laurence, A B Gottlieb, H G Kunkel
Title and authors | Publication | Year |
---|---|---|
Potential alteration of tumor microenvironments by β-mercaptoethanol
RE Click |
Future Oncology | 2021 |
Potential alteration of COVID-19 by beta-mercaptoethanol
RE Click |
Future Microbiology | 2020 |
Review: 2-Mercaptoethanol alteration of in vitro immune functions of species other than murine
RE Click |
Journal of Immunological Methods | 2013 |
Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systems
RE Click |
Oncology Discovery | 2013 |
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné |
Advances in Immunology Volume 110 | 2011 |
HIV and the Pathogenesis of AIDS
JA Levy |
2007 | |
Molecular Evolution of Viruses — Past and Present
Y Becker |
1996 | |
Retrovirus and filovirus “immunosuppressive motif” and the evolution of virus pathogenicity in HIV-1, HIV-2, and ebola viruses
Y Becker |
Virus Genes | 1995 |
Natural Killer Suppressor Factors in Sera from HIV-Infected Subjects
MA Goicoa, L Sen, PS Iannitelli, RA Diez, ME Estevez |
Scandinavian Journal of Immunology | 1995 |
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus
M Clerici, TA Wynn, JA Berzofsky, SP Blatt, CW Hendrix, A Sher, RL Coffman, GM Shearer |
Journal of Clinical Investigation | 1994 |
HIV-Induced T-Lymphocyte Depletion
E Schattner, J Laurence |
Clinics in Laboratory Medicine | 1994 |
Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals
M Clerici, FT Hakim, DJ Venzon, S Blatt, CW Hendrix, TA Wynn, GM Shearer |
Journal of Clinical Investigation | 1993 |
Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men
RK Chopra, NB Raj, JP Scally, AD Donnenberg, WH Adler, AJ Saah, JB Margolick |
Clinical & Experimental Immunology | 1993 |
TGF? and HIV Infection
M Lotz, P Seth |
Annals of the New York Academy of Sciences | 1993 |
Pathogenesis of human immunodeficiency virus infection
JA Levy |
Microbiological reviews | 1993 |
Partial Purification and Identification of an Immunosuppressive Factor in AIDS Sera
SK Oh, S Cerda, BG Lee, GC Blanchard, JE Walker, K Hartshorn |
AIDS Research and Human Retroviruses | 1993 |
A TH1→TH2 switch is a critical step in the etiology of HIV infection
M Clerici, GM Shearer |
Immunology Today | 1993 |
Progress in Immunology Vol. VIII
J Gergely, M Benczúr, A Erdei, A Falus, G Füst, G Medgyesi, G Petrányi, É Rajnavölgyi |
1993 | |
Type D SRV‐2 virus‐specific CD8 + and CD4 ‐ CD8 ‐ T cells that regulate virus‐induced T cell proliferation in Celebes macaques
A Malley, N Pangares, SK Mayo, M ZelenyPooley, JV Torres, E Benjamin, MK Axthelm |
Journal of Medical Primatology | 1993 |
Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men.
Chopra RK, Raj NB, Scally JP, Donnenberg AD, Adler WH, Saah AJ, Margolick JB |
Clinical & Experimental Immunology | 1993 |
Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2
A Ammar, Y Sahraoui, A Tsapis, AM Bertoli, C Jasmin, V Georgoulias |
Journal of Clinical Investigation | 1992 |
CD8+CD11+Suppressor Cells in HIV-Infected Asymptomatic Patients: Effect on HIV-Specific Cytotoxicity
SK Kundu, TC Merigan |
Viral Immunology | 1992 |
A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses
M Clerici, E Roilides, CS Via, PA Pizzo, GM Shearer |
Proceedings of the National Academy of Sciences | 1992 |
Biological and biochemical characterization of a factor produced spontaneously by adherent cells of human immunodeficiency virus-infected patients inhibiting interleukin-2 receptor alpha chain (Tac) expression on normal T cells
A Ammar, C Cibert, AM Bertoli, V Tsilivakos, C Jasmin, V Georgoulias |
Journal of Clinical Investigation | 1991 |
Correlation of Spontaneous Suppressor Cell Activity with Progression of Human Immunodeficiency Virus Infection
G Mullin, L Mayer |
AIDS Research and Human Retroviruses | 1991 |
Impaired in vitro growth of peripheral blood hematopoietic progenitor cells in HIV-infected patients: Evidence of an inhibitory effect of autologous T lymphocytes
E Balleari, S Timitilli, F Puppo, L Gaffuri, C Musselli, F Rizzo, F Indiveri, R Ghio |
Annals of Hematology | 1991 |
Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection
M Clerici, GM Shearer, CS Via, DR Lucey, E Roilides, PA Pizzo |
European Journal of Immunology | 1991 |
In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus
HN Steinberg, CS Crumpacker, PA Chatis |
Journal of virology | 1991 |
Human nonspecific suppressive lymphokines
MT Halpern |
Journal of Clinical Immunology | 1991 |
A Cluster of <i>Pneumocystis carinii</i> Pneumonia in Adults without Predisposing Illnesses
JL Jacobs, DM Libby, RA Winters, DM Gelmont, ED Fried, BJ Hartman, J Laurence |
New England Journal of Medicine | 1991 |
Cellular immunology of HIV infection
M Clerici, GM Shearer |
Clinical Immunology Newsletter | 1991 |
A role for CD8+ T lymphocytes in the pathogenesis of AIDS
A Aranda-Anzaldo |
Research in Immunology | 1991 |
The Immunopathogenesis of AIDS
JR Baker, T Leigh |
Dermatologic Clinics | 1991 |
Human immunodeficiency virus infection of monocytes: relationship to Fc-gamma receptors and antibody-dependent viral enhancement
J Laurence, A Saunders, E Early, JE Salmon |
Immunology | 1990 |
Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection
J Kekow, W Wachsman, JA McCutchan, M Cronin, DA Carson, M Lotz |
Proceedings of the National Academy of Sciences | 1990 |
A soluble inhibitor of T lymphocyte function induced by HIV-1 infection of CD4+ T cells: Characterization of a cellular protein and its relationship to p15E
J Laurence, J Kulkosky, B Dong, E Early, R Snyderman, GJ Cianciolo |
Cellular Immunology | 1990 |
Pathophysiological mechanisms of HIV-induced defects in haematopoiesis: pathology of the bone marrow
HJ Stutte, H Müller, S Falk, HL Schmidts |
Research in Virology | 1990 |
Neue Entwicklungen in der Dermatologie
OP Hornstein, M Hundeiker, J Schönfeld |
1990 | |
Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion
J Laurence, SM Friedman, EK Chartash, MK Crow, DN Posnett |
Journal of Clinical Investigation | 1989 |
LETTERS TO THE EDITOR
CS Lieber, LM DeCarli |
Nutrition Reviews | 1989 |
2-Mercaptoethanol and n-acetylcysteine enhance T cell colony formation in AIDS and ARC
J Wu, EM Levy, PH Black |
Clinical & Experimental Immunology | 1989 |
Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus
J Bentin, CD Tsoukas, JA McCutchan, SA Spector, DD Richman, JH Vaughan |
Journal of Clinical Immunology | 1989 |
4 Viruses and bone marrow failure
G Kurtzman, N Young |
Baillière's Clinical Haematology | 1989 |
Human Malignancies
D Drahovsky, B Kornhuber |
1989 | |
Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects
PJ Klasse, R Pipkorn, J Blomberg |
Proceedings of the National Academy of Sciences | 1988 |
Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection
R Leonard, D Zagury, I Desportes, J Bernard, JF Zagury, RC Gallo |
Proceedings of the National Academy of Sciences | 1988 |
Serum suppressive activity of HIV seropositive patients
D Israel-Biet, M Ekwalanga, A Venet, P Even, JM Andrieu |
Clinical & Experimental Immunology | 1988 |
Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response
TC Chanh, RC Kennedy, P Kanda |
Cellular Immunology | 1988 |
Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides
R Cauda, M Tumbarello, L Ortona, P Kanda, RC Kennedy, TC Chanh |
Cellular Immunology | 1988 |
Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus
WE Robinson, WM Mitchell, WH Chambers, SS Schuffman, DC Montefiori, TN Oeltmann |
Human Pathology | 1988 |
Human immunodeficiency virus-induced cytotoxicity for CD8 cells from some normal donors and virus-specific induction of a suppressor factor
LA Henderson, NM Qureshi, S Rasheed, R Garry |
Clinical Immunology and Immunopathology | 1988 |
Mysteries of HIV: challenges for therapy and prevention
JA Levy |
Nature | 1988 |
Clinical Use of Antiviral Drugs
ED Clercq |
1988 | |
Abnormalities of hematopoesis in the acquired immunodeficiency syndrome
A Ganser |
Blut Zeitschrift für die Gesamte Blutforschung | 1988 |
Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome
CC Stella, A Ganser, D Hoelzer |
Journal of Clinical Investigation | 1987 |
PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro
J Laurence, J Kulkosky, SM Friedman, DN Posnett, PO Ts'o |
Journal of Clinical Investigation | 1987 |
Stages in LAV/HTLV-III Lymphadenitis
G Palleshn, J Gerstoft, L Mathiesen |
Scandinavian Journal of Immunology | 1987 |
Cytotoxic Factors Secreted by Cells Infected by Human Immunodeficiency Virus Type I
L Ratner, SH Polmar, N Paul, N Ruddle |
AIDS Research and Human Retroviruses | 1987 |
Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2
Y Lunardi-Iskandar, V Georgoulias, D Vittecoq, MT Nugeyre, A Ammar, C Clemenceau, F Barre-Sinoussi, JC Chermann, L Schwartzenberg, C Jasmin |
Leukemia Research | 1987 |
The impact of the AIDS epidemic on therapeutic hemapheresis
DD Kiprov, S Romanick-Schmiedl |
Plasma Therapy and Transfusion Technology | 1987 |
Development of Antiretroviral Therapy for the Acquired Immunodeficiency Syndrome and Related Disorders
R Yarchoan, S Broder |
New England Journal of Medicine | 1987 |
Suppression of in vitro haematopoiesis following human immunodeficiency virus infection
RE Donahue, MM Johnson, LI Zon, SC Clark, JE Groopman |
Nature | 1987 |
Blood, Blood Products — and AIDS —
R Madhok, CD Forbes, BL Evatt |
1987 | |
Antiviral Therapy in AIDS: Clinical Pharmacological Properties and Therapeutic Experience to Date
EG Sandström, JC Kaplan |
Drugs | 1987 |
Early Defect of Phagocytic Cell Function in Subjects at Risk for Acquired Immunodeficiency Syndrome
ME Estevez, IJ Ballart, RA Diez, N Planes, C Scaglione, L Sen |
Scandinavian Journal of Immunology | 1986 |
Treatment of the acquired immune deficiency syndrome
S Gupta, MS Gottlieb |
Journal of Clinical Immunology | 1986 |
Unique T-Cell Immune Abnormalities in the Development of Acquired Immune Deficiency Syndrome (AIDS)
GM Shearer, DC Bernstein |
Cancer Investigation | 1986 |
Selective activation of functional suppressor cells by human seminal fluid
SS Witkin |
Clinical & Experimental Immunology | 1986 |
Impaired antibody-dependent cell-mediated cytotoxic activity in patients with the acquired immunodeficiency syndrome
BS Bender, FA Auger, TC Quinn, R Redfield, J Gold, TM Folks |
Clinical & Experimental Immunology | 1986 |
PARTIAL PLASMA EXCHANGE IN PATIENTS WITH AIDS AND KAPOSI'S SARCOMA. PLASMAPHERESIS IN AIDS
RF Reiss, P Rubinstein, A Friedman-Kien, LJ Laubenstein, D Ciavarella, J Smith, M Walker |
Aids Research | 1986 |
PLASMA PROTEIN ALTERATIONS IN AIDS AND HEMOPHILIA A
VK Dayal, MA Lea, YS Arkel |
Aids Research | 1986 |
Laboratory investigation of pediatric acquired immunodeficiency syndrome
AJ Ammann, J Levy |
Clinical Immunology and Immunopathology | 1986 |
Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers
MP Nair, TJ Laing, SA Schwartz |
Clinical Immunology and Immunopathology | 1986 |
Inhibition of interleukin 2 production and expression of the interleukin 2 receptor by plasma from acquired immune deficiency syndrome patients
JL Farmer, AA Gottlieb, T Nishihara |
Clinical Immunology and Immunopathology | 1986 |
Suppression of concanavalin A-induced blastogenesis by HTLV-III-infected H9 cells
EG Sandstrom, C Andrews, RT Schooley, R Byington, MS Hirsch |
Clinical Immunology and Immunopathology | 1986 |
Defective T-cell differentiation in acquired immune deficiency syndrome (AIDS)
EM Levy, JC Beldekas, KH Mayer, PH Black |
Journal of Clinical Immunology | 1986 |
The acquired immunodeficiency syndrome (AIDS)
FS Rosen |
Journal of Clinical Investigation | 1985 |
Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes
JP Siegel, JY Djeu, NI Stocks, H Masur, EP Gelmann, GV Quinnan |
Journal of Clinical Investigation | 1985 |
Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis
EM Carvalho, R Badaró, SG Reed, TC Jones, WD Johnson |
Journal of Clinical Investigation | 1985 |
Purification and In Vitro Growth of Human Epidermal Basal Keratinocytes Using a Monoclonal Antibody
AB Gottlieb, DN Posnett, MK Crow, T Horikoshi, L Mayer, DM Carter |
Journal of Investigative Dermatology | 1985 |
Immune Regulation: What Immunodeficiency Disease Has Taught Us
DW Wara |
Journal of Investigative Dermatology | 1985 |
Henry G. Kunkel 1916-1983. An appreciation of the man and his scientific contributions & a bibliography of his research papers
AG Bearn, FJ Dixon, B Benacerraf |
Journal of Experimental Medicine | 1985 |
Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome?
JC Gluckman, D Klatzmann, M Cavaille-Coll, E Brisson, A Messiah, D Lachiver, W Rozenbaum |
Clinical & Experimental Immunology | 1985 |
An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS
G Janossy, AJ Pinching, M Bofill, J Weber, JE McLaughlin, M Ornstein, K Ivory, JR Harris, M Favrot, DC Macdonald-Burns |
Clinical & Experimental Immunology | 1985 |
Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis
G Poli, B Bottazzi, R Acero, L Bersani, V Rossi, M Introna, A Lazzarin, M Galli, A Mantovani |
Clinical & Experimental Immunology | 1985 |
Malignant rabbit fibroma syndrome. A possible model for acquired immunodeficiency syndrome (AIDS)
DS Strayer, S Sell, JL Leibowitz |
The American Journal of Pathology | 1985 |
Suppressor T-cell activity in MRL/Mp-lpr/lpr mice: Differential effects on primary and memory antibody responses of MRL/Mp-lpr/lpr and MRL/Mp-+/+ spleen cells to thymus dependent and thymus independent antigens in vitro
DA Wilson |
Cellular Immunology | 1985 |
A membrane protein preferentially expressed by a subpopulation of immature lymphoid cells, epidermal basal keratinocytes, and other epithelial cells
AB Gottlieb, L Mayer, F Bonetti, DM Knowles, J Krueger, HG Kunkel, DM Carter |
Journal of the American Academy of Dermatology | 1985 |
Augmentation of mitogen-induced proliferative responses by in vitro indomethacin in patients with acquired immune deficiency syndrome and aids-related complex
MM Reddy, D Manvar, KK Ahuja, ML Moriarty, MH Grieco |
International Journal of Immunopharmacology | 1985 |
Evaluation of natural killer cell activity in patients with persistent generalized lymphadenopathy and acquired immunodeficiency syndrome
PC Creemers, DF Stark, WJ Boyko |
Clinical Immunology and Immunopathology | 1985 |
Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Retroviral Envelope Proteins
GJ Cianciolo, TD Copeland, S Oroszlan, R Snyderman |
Science | 1985 |
Naturally Occurring Antibodies Reactive with Sperm Proteins: Apparent Deficiency in AIDS Sera
TC Rodman, J Laurence, FH Pruslin, N Chiorazzi, R Winston |
Science | 1985 |
SOLUBLE FACTORS INHIBITORY FOR T-CELL- DEPENDENT IMMUNE RESPONSES IN PATIENTS WITH THE ACQUIRED IMMUNE DEFICIENCY SYNDROME AND ITS PRODROMES
J Laurence, AB Gottlieb, HG Kunkel |
Annals of the New York Academy of Sciences | 1984 |
EXOGENOUS INTERLEUKIN-2 AND MITOGEN RESPONSES IN AIDS PATIENTS
M Cavaille-Coll, E Brisson, D Klatzmann, JC Gluckman |
The Lancet | 1984 |
Impaired Production of Lymphokines and Immune (Gamma) Interferon in the Acquired Immunodeficiency Syndrome
HW Murray, BY Rubin, H Masur, RB Roberts |
New England Journal of Medicine | 1984 |
AIDS — An Immunologic Reevaluation
M Seligmann, L Chess, JL Fahey, AS Fauci, PJ Lachmann, J L'Age-Stehr, J Ngu, AJ Pinching, FS Rosen, TJ Spira, J Wybran |
New England Journal of Medicine | 1984 |
Inhibition of in vitro lymphocyte proliferation by serum from acquired immune deficiency syndrome patients depends on the ratio of cells to serum in culture
AK Hennig, RH Tomar |
Clinical Immunology and Immunopathology | 1984 |
Lymphadenopathy-Associated Viral Antibody in AIDS: Immune Correlations and Definition of a Carrier State
J Laurence, F Brun-Vezinet, SE Schutzer, C Rouzioux, D Klatzmann, F Barré-Sinoussi, JC Chermann, L Montagnier |
New England Journal of Medicine | 1984 |
The Immunology of AIDS
AJ Pinching |
Journal of the Royal Society of Medicine | 1984 |